Respiratory

A follow-up of a trial cohort showed that children aged 5 years born to pregnant smokers had improved airway function when vitamin C supplementation was administered during pregnancy compared to placebo.

The medication showed significant efficacy for treating patients with moderate to severe COPD exacerbations.

The FDA has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.

Moderna’s mRNA-1345 vaccine targets RSV in older adults.

Airsupra has been approved for as-needed use to reduce the risk of asthma exacerbations

With the respiratory season in full swing and COVID-19 continuing to infect, knowing the basics of the common cold, influenza, COVID-19, and respiratory syncytial virus can help ensure patients get the right care.

The US Food Administration has agreed to review an application for nirsevimab (Beyfortus; AstraZeneca and Sanofi) to protect infants against RSV.

Take a look back at our most popular respiratory coverage for 2022.

Study participants experienced better outcomes vs standard of care with a digital inhaler system.

Findings from research presented at the American College of Chest Physicians suggest the importance of selecting the right biologic from the start.

Besides providing education and counseling, pharmacists play a key role in the administration of vaccines.

Early interventions might preserve lung function, particularly in younger patients with frequent asthma exacerbations, say authors.

Secretions of fibroblast growth factor and granulocytic colony-stimulating growth factor in airway epithelium may be to blame.

The Patient-Centered Outcomes Research Institute (PCORI) has approved an award for the American Academy of Family Physicians (AAFP) of $31 million to fund a large comparative study of asthma treatments.

The specialty drug pipeline includes first- and next-in- class drugs across the oncology and immunology spaces.

Patience and antimicrobial stewardship are the keys to treating sinusitis

The increases had no impact on the efficacy of the drug and were rarely associated with symptoms or sequelae.

Epic research suggests that like COVID-19, flu and other viral pneumonias can result in long-term symptoms like fatigue and brain fog. Why that might be is open question.

Medical groups praise decision, but e-cigarette maker could return to U.S. market.

Proposal follows announced ban on menthol cigarettes, flavored cigars, and e-cig ban could be coming.

Six are currently on the market and more are in the pipeline.

New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.

The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.

Real-world study conducted in Japan shows Dupixent (dupilumab) reduced the number of annual severe asthma exacerbations by 53%, there were also adverse events associated with high eosinophil levels in patients who had switched from a different biologic before starting Dupixent.

Data suggest a smartphone application can boost physical activity and relieve symptoms of chronic obstructive pulmonary disease.

Xolair (omalizumab), Fasenra (benralizumab), Dupixent (dupilumab) and Nucala (mepolizumab) can now be self-administered.

Pharmacists are essential for managing complex CF regimens, monitoring their effectiveness, and improving adherence.

This year’s theme is focused on raising awareness about current gaps in care.

E-cigarettes may be helpful for smoking cessation.

Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.